Sunday, November 05, 2017 1:27:17 AM
Humanigen survived a brush with Martin Shkreli, but lost race for FDA voucher
By Peg Brickley
Wall Street Journal
Nov. 1, 2017 2:58 p.m. ET
Humanigen Inc., jailed fraudster Martin Shkreli’s final foray in the pharmaceutical industry, is circling the drain, according to a Securities and Exchange Commission filing Wednesday.
The company is unable to pay lenders that bailed it out of bankruptcy and is in talks about alternative asset-based transactions. Humanigen owes lenders Black Horse Capital LP and Nomis Bay Ltd. $16 million, the SEC filing says.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM